ArticleJournal of virology2025
CD36 is required for human sapovirus propagation.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- CD36 is a receptor for human sapovirus.Science advances · 2026Article
- Human Sapovirus in the Post-Rotavirus Vaccine Era: From an Overlooked Gastroenteritis Pathogen to a Target for Precision Surveillance.Reviews in medical virology · 2026Review
- Bile acids accumulate norovirus-like particles and enhance binding to and entry into human enteric epithelial cells.Journal of virology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Human sapoviruses (HuSaVs), which cause acute gastroenteritis, are highly diverse. Fifteen HuSaV genotype strains (GI.1-7, GII.1-5, -8, and GV.1-2) were efficiently propagated in the human duodenum-derived cell line HuTu80 when supplemented with conjugated bile acid (T. Oka, T.-C. Li, K. Yonemitsu, Y. Ami, et al., J Virol 98:e00639-24, 2024, https://doi.org/10.1128/jvi.00639-24). However, the host cellular factors involved in HuSaV infection and propagation remain unidentified. Using a knockout approach, we newly identified and confirmed that CD36 is a critical cellular protein for the propagation of all 15 HuSaV genotypes tested in HuTu80 cells. When the CD36 gene was re-expressed in CD36 gene knockout HuTu80 cells, all HuSaV genotype strains, except for GI.6 and GII.3, recovered their viral propagation ability. To further demonstrate that human CD36 is critical for HuSaV propagation, we expressed human CD36 in HuSaV-insensitive non-human origin cells. Of the 15 HuSaV genotype strains tested, 10 from GI, GII, and GV (GI.3, -5, -6, GII.1-3, -5, -8, GV.1, and GV.2) were propagated in Chinese Hamster Ovary-K1 cells, and six from GII (GII.1-5, -8) were propagated in Vero cells. Although there were differences in the propagation ability between the genotypes tested, at least one of the three cell lines engineered to express the human CD36 gene acquired HuSaV propagation potential, confirming that human CD36 is an essential cellular factor for HuSaV propagation.IMPORTANCEThe host cellular factor(s) involved in the infection and propagation of sapovirus, which causes acute gastroenteritis in humans, remain unclear. By using a loss-of-gene function approach with a potential physiological infection site derived from a human cell line clone, which caused a marked cytopathic effect related to human sapovirus (HuSaV) propagation, we identified that CD36 was essential for the propagation of all 15 genotype strains of HuSaV tested. We confirmed different effects on distinct genotypes of HuSaV propagation by the re-expression of human CD36 in HuTu80 cells and human CD36 introduced into two non-human HuSaV-insensitive cells. This finding is an important step toward understanding common and genogroup/genotype-specific HuSaV propagation mechanisms, and the development of methods to control this highly contagious virus, including research on the development of anti-viral drugs and the establishment of HuSaV-susceptible animal models in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.